Shopping Cart
Remove All
Your shopping cart is currently empty
DPDPE TFA (88373-73-3 free base)
Copy Product Info
😃Good
Catalog No. TP2036LCas No. 172888-59-4
Alias DPDPE TFA
DPDPE TFA is selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo.
DPDPE TFA (88373-73-3 free base)
Copy Product Info😃Good
Purity: 99.39%
Catalog No. TP2036LAlias DPDPE TFACas No. 172888-59-4
DPDPE TFA is selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $68 | In Stock | In Stock | |
| 5 mg | $163 | In Stock | In Stock | |
| 10 mg | $248 | In Stock | In Stock | |
| 25 mg | $406 | In Stock | In Stock | |
| 50 mg | $566 | In Stock | In Stock | |
| 100 mg | $762 | In Stock | In Stock | |
| 200 mg | $987 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.39%
Appearance:Solid
Color:White
Contact us for more batch information
Product Introduction
DPDPE TFA (88373-73-3 free base) AI Summary
DPDPE TFA (88373-73-3 free base) exhibits varied bioactivities across different cell types, showing both stimulatory and inhibitory effects on cell viability. It generally enhances growth rates in HEK293T cells, mainly promotes but occasionally inhibits growth in U2OS cells, and predominantly enhances growth rates while moderately inhibiting growth in human fibroblasts. The compound also shows variable effects on the thermal shift assay, exhibiting both stabilizing and destabilizing effects on different protein domains, suggesting complex interactions with protein structures. Additionally, DPDPE TFA (88373-73-3 free base) demonstrates bioactivity in GPCR beta-arrestin recruitment assays, targeting various receptors such as S1PR1, APLNR, C5AR1, FFAR4, GPR35, and others, with a mix of agonist and antagonist effects and varying degrees of maximum stimulation and inhibition..
Note: Summary generated by AI. Data source: ChEMBL 
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | DPDPE TFA is selective δ-opioid receptor agonist peptide. Inhibits electrically stimulated contraction of mouse vas deferens in vitro (EC50 = 5.2 nM), and is antinociceptive in vivo. |
| Synonyms | DPDPE TFA |
| Molecular Weight | 759.81 |
| Formula | C32H40F3N5O9S2 |
| Cas No. | 172888-59-4 |
| Smiles | O=C(O)C(F)(F)F.O=C([C@H](NC([C@H](CC1=CC=CC=C1)NC(CN2)=O)=O)C(C)(C)SSC(C)(C)[C@@H](NC([C@@H](N)CC3=CC=C(O)C=C3)=O)C2=O)O |
| Relative Density. | no data available |
| Sequence | Tyr-{Pen}-Gly-Phe-{Pen} (Disulfide bridge:Pen2-Pen5) |
| Sequence Short | Y{Pen}GF{Pen} (Disulfide bridge:Pen2-Pen5) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | DMSO: 10 mM, Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, and a total of 10 animals are to be administered, using a formulation of 
10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.Stock Solution Preparation:
Dissolve 2 mg of the compound in 100 μL DMSO to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
Preparation of the In Vivo Formulation:
1) Add 100 μL of the DMSO stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O and mix thoroughly until a homogeneous solution is obtained.
This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Keywords
Preview
Related Tags: buy DPDPE TFA (88373-73-3 free base) | purchase DPDPE TFA (88373-73-3 free base) | DPDPE TFA (88373-73-3 free base) cost | order DPDPE TFA (88373-73-3 free base) | DPDPE TFA (88373-73-3 free base) chemical structure | DPDPE TFA (88373-73-3 free base) formula | DPDPE TFA (88373-73-3 free base) molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.